The sale is minimal in both absolute and relative terms and appears tied to normal equity compensation management. Monitor Steinhart's actual Form 4 filings to see if the sale is completed, but this filing alone does not warrant a trading response.
Price Chart
Executive Summary
Richard I. Steinhart, an officer of BioXcel Therapeutics, filed a Form 144 to sell 6,845 shares of common stock valued at approximately $7,426. The shares were acquired via RSU vesting on May 4, 2026, under the company's equity compensation plan. Given the small absolute dollar amount relative to a $33M market cap and the source from equity compensation, this is a routine, low-significance filing.
Key Facts
- Officer Richard I. Steinhart filed Form 144 to sell 6,845 shares.
- Estimated value of proposed sale: ~$7,426.
- Shares acquired via RSU vesting on 2026-05-04 under issuer equity compensation plan.
- Market cap of BTAI is approximately $33 million.
- Broker is Merrill Lynch.
Financial Impact
Proposed sale of ~$7,426 represents roughly 0.02% of BTAI's $33M market cap.
Risk Factors
- While the filing is routine, completion of the sale could marginally increase selling pressure given the thin float at a $33M micro-cap.
- Insider selling ahead of clinical or regulatory catalysts could signal weaker management conviction, but this sale is too small to reliably indicate such sentiment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001964306-26-000252 |
| Document: 0001964306-26-000252-index.html | 0001964306-26-000252 |
| Document: 0001964306-26-000252.txt | 0001964306-26-000252 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 7w ago | 8-K | $0.1370 | awaiting T+60 | — | — |
Aug 28, 2026 8w ago | Press Release | $0.1814 | awaiting T+60 | — | — |
Aug 25, 2026 8w ago | 8-K | $0.7422 | awaiting T+60 | — | — |
Aug 11, 2026 10w ago | 8-K | $0.9320 | awaiting T+60 | — | — |
Aug 3, 2026 12w ago | 8-K | $0.8480 | awaiting T+60 | — | — |
Jul 6, 2026 16w ago | 8-K | $1.10 | awaiting T+60 | — | — |
May 22, 2026 22w ago | Insider Cluster | $1.22 $0.8274 | ▲ +32.18% | ▲ +34.91% | — |
May 20, 2026 22w ago | 144 | $1.14 $0.8900 | ▼ −21.93% | ▼ −26.23% | — |
May 15, 2026 23w ago | 8-K | $1.14 $0.9319 | ▼ −18.25% | ▼ −22.77% | — |
May 15, 2026 23w ago | Press Release | $1.14 $0.9319 | ▲ +18.25% | ▲ +22.77% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers